( NYSE:RMD )

News from ResMed Inc A wide array of domestic and global news stories; news topics include politics/government, business, technology, religion, sports/entertainment, science/nature, and health/lifestyle. Articles that appear in this section may be written in English or other languages.

Latest

Jun 29, 2017, 16:05 ET ResMed to Announce Fourth Quarter Fiscal Year 2017 Results

ResMed (NYSE: RMD) today announced it will report its fourth quarter of fiscal year 2017 results on Tuesday, August 1, 2017, after the New York...


May 22, 2017, 09:15 ET Big Data Yields Big Insights for Treatment of Central Sleep Apnea

According to a new ResMed-sponsored (NYSE:RMD) study, people with treatment-emergent central sleep apnea (CSA) have a significantly greater risk of...


May 21, 2017, 10:04 ET Clinical Trial Published in JAMA Offers New Hope for COPD Patients

People suffering from chronic obstructive pulmonary disease (COPD) – the third leading cause of death in the United States – may see their lives...


May 16, 2017, 09:00 ET Introducing the Softest CPAP Mask from ResMed

ResMed's AirTouch™ F20 full face mask with UltraSoft™ memory foam keeps patients on CPAP therapy comfortable throughout the night ResMed...


Apr 27, 2017, 16:05 ET ResMed Inc. Announces Results for the Third Quarter of Fiscal Year 2017

ResMed Inc. (NYSE: RMD) today announced results for its quarter ended March 31, 2017. Revenue for the quarter was $514.2 million, a 13 percent...


Apr 25, 2017, 09:19 ET ResMed Unveils AirMini - the World's Smallest CPAP

ResMed (NYSE: RMD) today unveiled its AirMini™, the world's smallest CPAP machine – a game-changer for people with sleep apnea. Experience the...


Mar 30, 2017, 16:05 ET ResMed to Announce Third Quarter Fiscal Year 2017 Results

ResMed Inc. (NYSE: RMD) today announced it will report its third quarter of fiscal year 2017 results on Thursday, April 27, 2017 after the New York...


Mar 20, 2017, 18:05 ET Research on Treating Sleep Apnea with Adaptive Servo-ventilation Published in the Journal of the American College of Cardiology (JACC)

ResMed (NYSE:RMD) today announced publication of a study in the Journal of the American College of Cardiology (JACC), which investigated whether...


Feb 13, 2017, 09:00 ET ResMed Named Global Leader in Remote Patient Monitoring

7.1 million patients worldwide are remotely monitored, 2 million from ResMed alone ResMed's global lead in remote patient monitoring kept...


Jan 23, 2017, 16:05 ET ResMed Inc. Announces Results for the Second Quarter of Fiscal Year 2017

ResMed Inc. (NYSE: RMD) today announced results for its quarter ended December 31, 2016. Revenue for the quarter was $530.4 million, a 17 percent...


Jan 20, 2017, 17:28 ET ResMed and BMC/3B Medical Settle Global Litigation

ResMed (NYSE:RMD), BMC (Beijing, China) and 3B Medical (Winter Haven, Florida) today announced they have agreed on a global settlement of all...


Jan 12, 2017, 03:00 ET ResMed's myAir™ Significantly Improves Adherence to CPAP Therapy in Patients with Sleep Apnea

ResMed (NYSE:RMD) today announced new European research from Price Waterhouse Coopers (PwC), revealing that patients with sleep apnea who use...


Jan 09, 2017, 09:00 ET FDA Clears World's Smallest CPAP, ResMed AirMini™

ResMed (NYSE:RMD) announced today at the 35th annual J.P. Morgan Healthcare Conference that the U.S. Food and Drug Administration has cleared...


Jan 06, 2017, 09:00 ET Dr. Oz, ResMed Launch SleepScore Labs - Promising the World a Better Night's Sleep

The world is about to find out how well it really sleeps – and how to sleep better – thanks to SleepScore Labs, a new company focused on helping...


Jan 04, 2017, 09:00 ET ResMed Reaches Historic One Billionth Night of Sleep Monitored

- World's largest repository of sleep data – a giant step forward for sleep medicine - Predictive analytics from data will improve therapy and...


Dec 20, 2016, 09:00 ET ResMed Appoints Carlos Nunez, MD, as Chief Medical Officer

ResMed (NYSE: RMD) today announced that industry leader Carlos M. Nunez, MD, will become ResMed's chief medical officer, effective January 3, 2017....


Dec 19, 2016, 16:05 ET ResMed to Announce Second Quarter Fiscal Year 2017 Results

ResMed Inc. (NYSE: RMD) today announced it will report its second quarter of fiscal year 2017 results on Monday, January 23, 2017 after the New...


Nov 01, 2016, 09:05 ET ResMed Launches AirView Action Groups, the Ultimate Time-saver For Home Medical Equipment Providers

AirView also now widely available for Astral life support ventilators, the first and only ventilator connectivity of its kind ResMed...


Nov 01, 2016, 09:00 ET ResMed Introduces AirFit™ N20 and AirFit F20 CPAP Masks: A New Standard for Fit and Comfort

ResMed (NYSE:RMD) today introduced the AirFit N20 nasal mask and AirFit F20 full face mask for positive airway pressure (PAP) treatment of sleep...


Oct 25, 2016, 16:05 ET ResMed Inc. Announces Results for the First Quarter of Fiscal Year 2017

ResMed Inc. (NYSE: RMD) today announced results for its quarter ended September 30, 2016. Revenue for the quarter was $465.4 million, a 13...


Oct 25, 2016, 09:00 ET Results from World's Largest Study on Sleep Apnea and Digital Connected Care

In a new research study being presented tomorrow at the CHEST 2016 annual meeting, ResMed (NYSE: RMD) will share evidence that people who use a...


Oct 18, 2016, 09:00 ET National Sleep Survey Launch on "The Dr. Oz Show" to Determine America's Sleep Score

ResMed (NYSE: RMD), the global leader in medical devices and digital connected care for the diagnosis, treatment and management of sleep apnea, is...


Sep 27, 2016, 16:05 ET ResMed to Announce First Quarter Fiscal Year 2017 Results

 ResMed Inc. (NYSE: RMD) today announced it will report its first quarter of fiscal year 2017 results on Tuesday, October 25, 2016 after the...


Sep 06, 2016, 08:51 ET New Study Shows Using Non-Invasive Ventilation Therapy to Treat Patients with Chronic Obstructive Pulmonary Disorder (COPD) at Home Significantly Reduces Risk of Re-Hospitalization and Death

ResMed (NYSE: RMD) welcomed positive results from a multicenter, randomized controlled trial known as HOT-HMV. The study was presented today during...


Aug 17, 2016, 17:10 ET ResMed Takes Fisher & Paykel to Court over Patents

- ResMed files patent infringement actions against Fisher & Paykel Healthcare in U.S., German and New Zealand courts and in the U.S....